Keyword: Novasep

News

Axplora Opens cGMP Pilot Plant for Flow Chemistry in Leverkusen

25.07.2023 -

Axplora has completed the installation of a new cGMP (cyclic guanosine monophosphate) pilot unit at its German site in Leverkusen, costing more than €1 million.

Research & Innovation

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

22.02.2023 -

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.

News

Farmabios, Novasep and PharmaZell now Axplora

21.10.2022 -

Following the merger of French CDMO Novasep and German API maker PharmaZell in April this year, all brands of the two companies, including those of PharmaZell’s group...

News

Novasep‐PharmaZell Invests €7.3 Million in APIs

27.07.2022 -

Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its...

News

Novasep and PharmaZell Conclude Merger

19.04.2022 -

Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will...

News

Novasep Invests in API Capabilities

21.12.2021 -

Novasep, a French CDMO, has announced a €6 million investment to increase and modernize manufacturing capabilities at its Chasse-sur-Rhône site to support new generation...

News

Novasep and McSAF in ADC Partnership

26.11.2021 -

French CDMO Novasep is collaborating with compatriot biotech McSAF on the preclinical production of Adcitmer, a next-generation antibody drug conjugate (ADC) for treating...

News

Avid Bioservices Expanding Cell and Gene Therapy

25.10.2021 -

Avid Bioservices, a biologics-oriented CDMO based in the US state of California, is building a new plant in Costa Mesa, California, as part of a plan to expand its cell...